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Abstract Low-frequency oscillations in the basal ganglia
are prominent in patients with Parkinson’s disease off med-
ication. Correlative and more recent interventional studies
potentiallyimplicate these rhythms inthe pathophysiologyof
Parkinson’s disease. However, effect sizes have generally
been small and limited to bradykinesia. In this study, we
investigate whether these effects extend to rigidity and are
maintainedin the on-medication state.Westudied24sides in
12 patients on levodopa during bilateral stimulation of the
STN at 5, 10, 20, 50, 130 Hz and in the off-stimulation state.
Passiverigidity atthewristwas assessedclinicallyand witha
torque-based mechanical device. Low-frequency stimulation
at B20 Hz increased rigidity by 24 % overall (p = 0.035),
whereas high-frequency stimulation (130 Hz) reduced
rigidity by 18 % (p = 0.033). The effects of low-frequency
stimulation (5, 10 and 20 Hz) were well correlated with each
other for both ﬂexion and extension (r = 0.725 ± SEM
0.016and0.568 ± 0.009,respectively).Clinicalassessments
were unable to show an effect of low-frequency stimulation
but did show a signiﬁcant effect at 130 Hz (p = 0.002). This
study provides evidence consistent with a mechanistic
link between oscillatory activity at low frequency and
Parkinsonian rigidity and, in addition, validates a new
method for rigidity quantiﬁcation at the wrist.
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Introduction
Recordings of local ﬁeld potentials (LFPs) from the basal
ganglia of patients with Parkinson’s disease have shown
prominent oscillatory activity at frequencies under about
30 Hz (Alonso-Frech et al. 2006; Bronte-Stewart et al.
2009; Brown et al. 2001; Cassidy et al. 2002; Foffani et al.
2005;K u ¨hn et al. 2006; Marceglia et al. 2006; Weinberger
et al. 2006). Such activity is suppressed by treatment with
levodopa and by high-frequency deep brain stimulation
(Jenkinson and Brown 2011). Oscillatory activity has been
shown to correlate with rigidity-bradykinesia both in the
rest state and in response to treatment, although the fre-
quency band of interest has varied between studies from
8 Hz up to 35 Hz (Brown and Williams 2005; Chen et al.
2010;K u ¨hn et al. 2006;L o ´pez-Azca ´rate et al. 2010;
Pogosyan et al. 2010; Ray et al. 2008; Zaidel et al. 2010).
Indeed, to date, there is little evidence that any particular
low frequency of oscillation is any more predictive of
motor deﬁcit than another (Ku ¨hn et al. 2009). The above
correlative evidence of a link between oscillatory activity
across a fairly wide range of low frequencies and brady-
kinesia has been strengthened by a number of interven-
tional studies in which bradykinesia has been exacerbated
by stimulation of the subthalamic nucleus (STN) at 5, 10
and 20 Hz although effect sizes have been small (Chen
et al. 2007, 2011; Eusebio et al. 2008; Fogelson et al. 2005;
Timmermann et al. 2004).
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DOI 10.1007/s00221-012-3107-7Hitherto, however, there has been no evidence to sup-
port a direct causal link between low-frequency oscillatory
activity and rigidity. Here, we test for such a link by
stimulating the STN at low frequencies in patients with
Parkinson’s disease while we assess rigidity with an
objective mechanical device that allows continuous scalar
estimates of tone. We examined patients on their usual
antiparkinsonian medication, so as to avoid potential ceil-
ing effects whereby rigidity could not worsen further with
low-frequency stimulation. We hypothesized that stimula-
tion at frequencies B20 Hz would increase rigidity at the
wrist, while stimulation at clinically effective high fre-
quencies would reduce rigidity.
Methods
Subjects and surgery
The study was approved by the local ethics committee and
subjects gave their informed, written consent. Twelve
patients (mean age, 61.5 ± SEM 1.9 years; disease dura-
tion, 13.1 ± 1.6 years; see Table 1 for further details) with
idiopathic Parkinson’s disease were investigated 2.9 ±
0.8 years after implantation of bilateral deep brain stimu-
lation (DBS) electrodes into the STN. Indications for sur-
gery were advanced Parkinsonism with motor ﬂuctuations
and/or dyskinesias or tremor that could not be sufﬁciently
controlled by drugs. The DBS electrode used was model
3389 (Medtronic Neurological Division, Minneapolis,
USA) with four platinum–iridium cylindrical surfaces
(1.27-mm diameter and 1.5 mm length) and centre-to-
centre separations of 2 mm. Contacts 0 and 3 were the
most caudal and rostral contacts, respectively. STN elec-
trode trajectories were aimed at the dorsolateral STN. The
STN was identiﬁed on high-resolution T2 weighted
axial, magnetic resonance images. On the day of surgery,
a Cosman-Roberts-Wells
 (Radionics, Burlington, MA)
stereotactic base ring was applied to the patient’s scalp
under local anaesthetic. A stereotactic computed tomog-
raphy (CT) scan was obtained, and the images were fused
to the MR using Radionics Stereoplan
 software. The STN
was identiﬁed and targeted visually although concordance
with the Schaltenbrand and Wahren atlas (1977) was
conﬁrmed. The electrodes were introduced via a 2.7-mm
twist drill craniotomy in all cases. Correct placement of
DBS electrodes in the STN was supported intraoperatively
by loss of rigidity and/or tremor suppression with stimu-
lation and postoperatively by performing a stereotactic CT
scan that was fused to the T2-weighted MR images as
above. Operations were performed in two stages with
implantation of the pulse generator after 1 week of testing
to conﬁrm clinical effect.
Protocol
All patients were assessed on their usual medication.
Experiments were timed to begin at the mid-point of the
drug dosing at least 1 h after last dose. Clinical ‘on’ state
was conﬁrmed both by the patient and also by the attending
neurologist. Patients were studied with the STN stimulation
switched off and during bilateral STN stimulation at 5, 10,
20, 50 Hz and their usual therapeutic high-frequency set-
ting. The latter will be termed 130 Hz, although in two
patients, therapeutic stimulation was delivered at a higher
frequency (see Table 1). The order of stimulation frequen-
cies (including no stimulation) was pseudo-randomized
across patients, with the exception that, to minimize pro-
tocol length, the ﬁnal block was always the therapeutic
high-frequency setting. Stimulation contacts, amplitude and
pulse duration remained the same as utilized for chronic
therapeutic stimulation in each patient (see Table 1). The
study was performed in a double-blind manner with both the
patient and assessor of rigidity unaware of which stimula-
tion frequency was being used between 0 and 50 Hz. Eight
minutes elapsed after changing stimulation settings before
testing rigidity.
Rigidity assessment
Rigidity at each wrist was clinically assessed with item 22
of the motor section of the Uniﬁed Parkinson’s disease
rating scale (UPDRS). Half-points were used to increase
sensitivity (Chen et al. 2010;K u ¨hn et al. 2006). Thus,
rigidity scores were deﬁned as 0—Absent; 0.5—Slight or
detectable when activated by mirror or other movements
but present only occasionally/intermittently; 1—Consis-
tently slight or detectable only when activated by mirror or
other movements; 1.5—Rigidity detectable consistently but
very mild; 2—Mild to moderate; 2.5—Moderate to
marked; 3—Marked, but full range of motion easily
achieved; 3.5—Marked with some mild difﬁculty in
achieving full range of motion; 4—Severe, range of motion
achieved with difﬁculty; 4.5—Very severe, full range of
motion limited. However, clinical assessment alone has
poor sensitivity as well as high inter-rater and intra-rater
variability (Patrick et al. 2001; Prochazka et al. 1997). We,
therefore, followed clinical assessment with an objective
mechanical assessment of rigidity at each wrist that affor-
ded continuous scalar estimates. This was preferred to an
index of rigidity derived from EMG, as several studies
have conﬁrmed that torque-based methods of quantiﬁcation
are more strongly related to clinically determined rigidity
than electromyography-based metrics (Endo et al. 2009;
Levin et al. 2009; Park et al. 2011).
We assessed wrist torque in response to externally based
displacement imposed by the examiner rather than by a
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123motor. The former was preferred so as to limit anxiety and
reinforcement related to the use of a motor and ﬁxed
manipulandum. Angular displacement was measured using
an electronic goniometer across the wrist (TMS Interna-
tional B.V., Netherlands) that was calibrated using a
manual goniometer for each patient across the whole
angular range of displacement. Force was measured using a
strain gauge (Omegadyne LCM201-100N) mounted
between two horizontal aluminium bars (Fig. 1a). The
strain gauge had a linear range from 0 to 100 N ± 1% .
Force and angle measures were low-pass ﬁltered at 1 kHz,
sampled with a frequency of 2,048 Hz and recorded
through a commercial ampliﬁer (TMSI Port 7, TMS
International B.V., The Netherlands).
The metacarpophalangeal junction of the subject’s hand
was rested on the top bar of the device while the bottom bar
was controlled by the experimenter. The distance between
the MCP joint and the wrist was used to calculate torque
(force x distance). Patients were requested to look straight
ahead and minimize movement and speech. The hand was
then passively ﬂexed and extended as the experimenter
applied force in a sinusoidal, vertical, manner. Velocity
was controlled by delivering a ﬁxed displacement at a set
frequency of 0.75 Hz using a visual metronome that was
visible to the experimenter but not the patient. This fre-
quency falls in the range used clinically to determine
rigidity with the motor UPDRS (Shapiro et al. 2007). The
experimenter moved the wrist through half the full range of
Table 1 Clinical details of patients
Case Age
(years)
Disease
duration/
time since
operation
(years)
Predominant
symptom
Preop levodopa
challenge UPDRS
part III on/off
c
Rigidity
(L ? R arm)
off/on HFS
a
Medication
(total daily dose)
Chronic stimulation
parameters
1 65 24/2 Tremor (R side) 14/32 1.5/0 Co-beneldopa 1,125 mg
Ropinirole 8 mg
Amantadine 100 mg
L 3.1 V 60 ls 130 Hz
R 2.6 V 60 ls 130 Hz
2 56 6/1 Tremor (R side) 22/43 5/2.5 Co-careldopa 1,000 mg
Entacapone 800 mg
Selegeline 10 mg
Co-beneldopa 125 mg
L 3.9 V 60 ls 130 Hz
R 1.5v 60 ls 130 Hz
3 60 11/6 R sided rigidity/tremor 28/45 3/2.5 Co-careldopa 312.5 mg L 3.4 V 60 ls 180 Hz
R 2.9 V 60 ls 180 Hz
4 71 17/2 Dyskinesias 8/38 3/1 Co-beneldopa 1,725 mg
Amantadine 200 mg
L 2.8 V 60 ls 130 Hz
R 3.3 V 60 ls 130 Hz
5 65 18/2 Rigidity L side 7/34 1.5/2 Co-beneldopa 1,000 mg L 2.8 V 60 ls 130 Hz
R 3.2 V 60 ls 130 Hz
6 68 10/0.5 Bradykinesia 2/17 0.5/1 Rotigitine 4 mg
Co-beneldopa 1,000 mg
L 3.4 V 60 ls 130 Hz
R 3.4 V 90 ls 130 Hz
7 49 10/2 R leg dyskinesia.
Bradykinesia/tremor
10/35 2/0.5 Co-careldopa 500 mg
Pramipexole 2.1 mg
L 2.6 V 90 ls 130 Hz
R 2.3 V 60 ls 130 Hz
8 64 12/2 R sided rigidity 17/47 3/3 Co-beneldopa 500 mg
Tolcapone 300 mg
L 3.6 V 90 ls 130 Hz
R 3.2 V 90 ls 130 Hz
9 62 13/3 R sided tremor and
dyskinesias
15/38 3.5/2 Co-beneldopa 1,125 mg
Ropinirole 24 mg
L 3.9 V 90 ls 130 Hz
R 2.4 V 60 ls 130 Hz
10 56 19/10 Bradykinesia/rigidity
b/51 (off) 4/4 Co-careldopa 375 mg
Ropinirole 8 mg
L 3.5 V 90 ls 185 Hz
R 3.1 V 120 ls 185 Hz
11 55 6/1.5 Leg tremors. Drug
induced nausea
6/27 7.5/3.5 Co-careldopa 500 mg L 3.5 V 90 ls 130 Hz
R 3.4 V 20 ls 130 Hz
12 67 11/2.5 Severe off periods 7/23 2.5/0.5 Co-beneldopa 312.5 mg
Ropinirole 3 mg
L 3 V 60us 130 Hz
R 3.1 V 60 ls 130 Hz
a Assessed as item 22 of motor section of UPDRS
b Preop off drugs score missing
c UPDRS III tested after overnight withdrawal of all antiparkinsonian medication and again after a test dose of a minimum of 200 mg levodopa.
Test performed less than 3 months before surgery
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123comfortable displacement around the horizontal plane.
Patients were encouraged to fully relax and not to assist
with movement. Active assistance was identiﬁed by
subjective reduction in force on the strain gauge device
prior to the start of a cycle, and these sections were
removed and rigidity assessment repeated after patient re-
instruction. A minimum of 14 cycles per condition was
performed.
Analysis
We derived the elastic coefﬁcient of the wrist calculated
from unit torque/unit angular displacement (Endo et al.
2009; Powell et al. 2012). Rigidity was calculated ofﬂine in
MATLAB (v. 7.11.0, R2010b, The Mathworks, Natik, MA,
USA) using custom written scripts. The oscillatory time
series of both torque and angular displacement were pass-
band ﬁltered between 0.25 and 1.25 Hz using a 4th order
Butterworth ﬁlter to remove offset, noise and any super-
added tremor. Continuous oscillatory traces were broken
into individual cycles using the phase determined through a
Hilbert transform. Displacement was plotted against torque
(x and y, respectively) for the central 50 % of each cycle,
and this was ﬁtted with a linear regression line (Fig. 1b).
The gradient of this line was taken as the elastic coefﬁcient
and the procedure repeated for each cycle of movement.
The mean elastic coefﬁcient of the last 12 cycles performed
in each experimental run was taken as our index of rigidity
for that condition. Exclusion of the ﬁrst few movement
cycles allowed the subject to relax before assessments were
made. This procedure was separately performed for both
the ﬂexion and extension phase of each cycle.
All rigidity values were normalized to the off-stimula-
tion state [(stim off - stim (f)/stim off)] to determine
percentage change compared to baseline, and signs inver-
ted so that a positive % change represented an increase in
rigidity. Kolmogorov–Smirnov tests conﬁrmed the nor-
mality of the % changes estimated with the device, and so
stimulation frequency effects were evaluated with t tests.
Signiﬁcant effects were reported if they remained signiﬁ-
cant according to the False Discovery Rate procedure and
t tests were two tailed. Changes in clinical assessments of
rigidity were assessed with non-parametric Wilcoxon
signed rank tests. Clinical assessments of rigidity were
logarithmically transformed prior to correlation with
device measurements, given the known logarithmic nature
of psychophysical observation (Weber’s law). Correlations
were performed using Spearman’s correlation. Statistical
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Fig. 1 a Photograph of mechanical rigidity device. b Time series of
force and displacement during stimulation at 5 Hz from subject 7
(UPDRS—clinical rigidity score—1). c Superimposed torque–angular
displacement cycles during stimulation at 5 Hz. d Schematic of
analytical method for determining rigidity coefﬁcients in ﬂexion and
extension. A single displacement cycle is shown from stimulation at
5H z( blue line) with linear regression of mid-cycle phase (dashed
lines 50 % of cycle) for both ﬂexion and extension (red line). The
gradient of the regression line is taken as the rigidity for that cycle
b
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123analysis was performed in the Statistical Program for
Social Sciences (SPSS) statistical software (version 17.0,
SPSS Inc., Chicago, IL, USA).
Results
Our a priori hypothesis was that the effects of stimulation
at frequencies B20 Hz would be related and lead to an
increase in rigidity, whereas the effect of stimulation at
130 Hz would lead to a decrease in rigidity at the wrist.
Objective assessment of tone with our device bores this
out (Fig. 2). The effects of stimulation at 5, 10 and 20 Hz
all correlated with one another, whether extension
or ﬂexion was tested (mean Fisher transformed
r = 0.725 ± SEM 0.016 and 0.568 ± 0.009, respectively,
all correlations individually signiﬁcant, p\0.05). How-
ever, correlations between the effects of stimulation at
5–20 Hz with those of stimulation at 130 Hz were weak
(r = 0.229 ± 0.042 and r = 0.308 ± 0.121 for extension
and ﬂexion, all but one non-signiﬁcant). The similarity in
the response to low-frequency (5, 10 and 20 Hz) stimu-
lation in ﬂexion and extension seen at the group level
(Fig. 2) was also found at the level of individual limbs.
Thus, the maximum rigidity in the low-frequency blocks
in ﬂexion was at the same stimulation frequency as in
extension in 19 out of 24 sides (Fisher’s exact test, two-
tailed p = 0.0032, compared to the 8 out of 24 instances
expected by chance). Across movement phases, the
maximum rigidity in the low-frequency blocks was at
5 Hz on 17 sides, 10 Hz on 17 sides and 20 Hz on 14
sides.
Thus, effects on ﬂexion and extension were very
similar (contrast Fig. 2a, b), and so in subsequent anal-
yses, we averaged changes across ﬂexion and extension.
Thereafter, we averaged the effects of 5–20 Hz stimu-
lation and compared this to baseline (no stimulation) and
to the effect of stimulation at therapeutic frequency,
130 Hz. Low-frequency stimulation (5–20 Hz) increased
rigidity by 24.0 % (one-sample t test, t(df 23) = 2.240,
p = 0.035), whereas high-frequency stimulation reduced
rigidity by -17.8 % (one-sample t test, t(df 23) =
-2.284, p = 0.033). The effects of low- and high-fre-
quency stimulation were also different (paired t test,
t(df 23) = 3.511, p = 0.002).
We were unable to demonstrate an effect of low-fre-
quency stimulation when using double-blinded clinical
assessment of rigidity (Fig. 3). As above, we averaged the
effects of 5–20 Hz stimulation and compared this to
baseline and to the effect of stimulation at therapeutic
frequency, 130 Hz. Low-frequency stimulation increased
rigidity by 1 % (Wilcoxon test, p = 0.87), whereas high-
frequency stimulation reduced rigidity by 45 % (Wilcoxon
test, p = 0.002). The effects of low- and high-frequency
stimulation were also different (Wilcoxon test, p = 0.002).
Clinical and device assessments were signiﬁcantly corre-
lated, although the relationship was not strong (Spearman’s
rho = 0.382, p = 0.002; Fig. 4).
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Fig. 2 Effects of bilateral stimulation of the STN at different frequencies
onquantitativerigiditycomparedtooff-stimulationstate.aMean(±SEM)
percentagechangeinextensioncoefﬁcients.bPercentagechangeinﬂexion
coefﬁcients. Stimulation at frequencies B20 Hz exacerbates rigidity,
whereas stimulation at the therapeutic frequency of 130 Hz tends to
improve rigidity. The pattern is similar for extension and ﬂexion.
c Percentage change of averaged low-frequency (5,10 and 20) ﬂexion/
extension coefﬁcients with signiﬁcance. Low-frequency stimulation
signiﬁcantlyincreasesrigidity(*p\0.05),andhigh-frequencystimulation
signiﬁcantly reduces rigidity (*p\0.05). Low-frequency and high-fre-
quency stimulation are signiﬁcantly different (**p\0.01). Twenty-four
upper limbs were tested with patients on Parkinsonian medication
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123Discussion
This study shows a worsening of objectively recorded
rigidity in patients with Parkinson’s disease during low-
frequency stimulation of the subthalamic nucleus and thus
provides further evidence consistent with a causal role for
these oscillations in the pathophysiology of the condition.
Recordings of the effects of low-frequency stimulation
were made under double-blind conditions. Clinical
assessment of tone made under the same conditions,
however, did not reveal any change, perhaps because of the
acknowledged poor sensitivity and high variability of this
technique (Patrick et al. 2001; Prochazka et al. 1997). The
latter may relate to its subjectivity and its rating on a
bounded, ordinal rating scale. The poor sensitivity and high
variability of clinical assessment may also explain the
relatively modest correlation between mechanical and
clinical assessments of rigidity in the present investigation.
Such modest but signiﬁcant correlations between objective
and clinical assessments of rigidity have also previously
been reported in the setting of DBS (Levin et al. 2009).
Previous studies have investigated the effect of low-
frequency stimulation on bradykinesia in patients with
Parkinson’s disease and generally found a modest, delete-
rious effect with stimulation over 5–20 Hz raising doubt on
the scope of the mechanistic role of low-frequency oscil-
lations (Chen et al. 2011). The results presented here are
remarkable for a larger effect size (24 %) and for extending
evidence of a link between low-frequency stimulation and
impairment to rigidity. As previous studies have all been
performed off medication, it is possible that a ﬂoor effect
limited the size of previous results, though it is also pos-
sible that rigidity is more sensitive than bradykinesia to
low-frequency stimulation. In studying patients on medi-
cation, we limited any confounding ﬂoor effect; however, it
should be acknowledged that baseline rigidity may be more
variable on medication than off medication, and this may
have contributed to the variance in our recordings.
Still, although the current results provide evidence con-
sistent with a mechanistic link between oscillatory activity
at low frequency (in this case driven by external stimula-
tion), and rigidity, our effect size was still only moderate.
As discussed elsewhere, this may have arisen because of the
imperfect nature of our intervention with respect to tem-
poral and spatial patterning, so that electrical stimulation
was not a precise mimic of spontaneous oscillatory activity
in the circuit (Brown 2007). Nevertheless, the precise scale
of the contribution of low-frequency stimulation to rigidity
in Parkinson’s disease remains unclear.
Both objective and clinical assessments conﬁrmed that
high-frequency stimulation improved rigidity in our series
of patients on medication, although clinical assessments
may have been biased by the fact that the assessment of
stimulation at 130 Hz was performed last and was not
double blinded. It is well established that high-frequency
stimulation of the subthalamic nucleus improves rigidity in
patients withdrawn from medication (Benabid et al. 2009),
and some investigations, as here, have also reported
improvements during stimulation in medicated patients
(Maurer et al. 2003; Raoul et al. 2012).
Our data reinforce previous studies showing a correla-
tion between low-frequency synchrony and aggregate
measures of bradykinesia and rigidity (Brown and Wil-
liams 2005; Chen et al. 2010;K u ¨hn et al. 2006;L o ´pez-
Azca ´rate et al. 2010; Pogosyan et al. 2010; Ray et al. 2008)
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Fig. 4 Scatter plot of clinical rigidity assessment versus log quan-
titative rigidity scores. There is a correlation between clinical rigidity
scores and log rigidity scores, rho = 0.361, p = 0.002. Rigidity was
clinically assessed using item 22 of the motor UPDRS. Data are
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123and of rigidity alone (Hammond et al. 2007; Zaidel et al.
2010). One of the latter studies reported peak correlations
with rigidity at 15 Hz (Zaidel et al. 2010). With respect to
rigidity, it is possible that low-frequency synchrony in
basal ganglia-cortical loops may, under physiological
conditions, promote postural activity through the upregu-
lation of the effects of sensory inputs that reinforce such
activity (Androulidakis et al. 2006; Gilbertson et al. 2005;
Lalo et al. 2007). This upregulation may be further
heightened when low-frequency synchrony is exaggerated
in Parkinson’s disease (Hammond et al. 2007). This,
however, remains speculative.
Finally, the present study introduces a new method of
rigidity assessment in patients with Parkinson’s disease
which, although simple to implement, mimicking clinical
evaluation, affords objective, continuous scalar estimates
of tone, rather than the bounded, ordinal clinical assess-
ment using the motor UPDRS.
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